Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05268250 · ClinicalTrials.gov registry record · NA
Remedy to Diabetes Distress (R2D2): A Scalable Screen to Treat Program for School-age Families
A NA study of Type 1 Diabetes, sponsored by Nemours Children's Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 2
- Study locations
NCT05268250 is a NA study of Type 1 Diabetes that is actively recruiting participants, run by Nemours Children's Clinic. The registered enrollment target is 180 participants, below the 823-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (78% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05268250, a NA study of Type 1 Diabetes, is actively recruiting participants, sponsored by Nemours Children's Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 2
- Study locations
Study Summary
This R01 is in response to RFA-DK-19-021, Treating Diabetes Distress to Improve Glycemic Outcomes in Type 1 Diabetes. The objective is to test the feasibility and acceptability of a novel, practical, and potentially scalable screen to treat program for diabetes distress in families of school-age children with T1D (called Remedy to Diabetes Distress \[R2D2\]) and to test the initial efficacy of R2D2 to reduce diabetes distress to improve children's glycemic control.
Conditions Studied
Interventions
- BEHAVIORAL R2D2 mHealth intervention
Study Locations (2)
Florida
- Nemours Children's Health - Jacksonville
Missouri
- Children's Mercy Kansas City - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2024-02-26 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05268250
The ClinicalTrials.gov registry entry for NCT05268250 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 823-participant average among 178 other Type 1 Diabetes trials with a reported enrollment target (78% lower). The listed sponsor is Nemours Children's Clinic, which has 108 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Type 1 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which R2D2 mHealth intervention is the first listed.
NCT05268250 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Missouri.
Frequently Asked Questions
What is clinical trial NCT05268250 about?
NCT05268250 is a clinical study titled "Remedy to Diabetes Distress (R2D2): A Scalable Screen to Treat Program for School-age Families". This R01 is in response to RFA-DK-19-021, Treating Diabetes Distress to Improve Glycemic Outcomes in Type 1 Diabetes. The objective is to test the feasibility and acceptability of a novel, practical, and potentially scalable screen to treat program for diabetes distress in families of school-age chi...
What is the current status of trial NCT05268250?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2024-02-26. Estimated completion is 2026-08-31.
What conditions does trial NCT05268250 study?
This clinical trial studies the following conditions: Type 1 Diabetes.
What interventions are being tested in trial NCT05268250?
The interventions under investigation include: R2D2 mHealth intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05268250?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05268250 being conducted?
This trial has 2 study locations across Florida, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 1 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
REAL-Fam Feasibility Study for Youth Diabetes Management
RECRUITING · NA
-
AIDANET Pediatrics
RECRUITING · NA
-
A Study Comparing Dexcom Continuous Glucose Monitoring to Point of Care Glucose Testing for the Management of Hospital and Post-Discharge Subjects With Type 1 Diabetes
RECRUITING · NA
-
Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 Diabetes Using Automated Insulin Delivery
RECRUITING · NA
-
EMPoWER Study - Strengths-based Behavioral Intervention for Youth With Type 1 Diabetes
RECRUITING · NA
-
Safety and Feasibility of a Machine-Learning Bolus Priming Added to Existing Control Algorithm
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.